The threat of the coronavirus is serious and we all need to work together to slow to the spread in order to make sure our healthcare system can absorb the coming increase in demand for care.
We can reduce this through things like social distancing, avoiding large gatherings indoors, canceling non-essential events, and telecommuting when possible. The CDC has especially encouraged those at higher risk of getting very sick from COVID-19 - older individuals and those with underlying medical conditions like heart disease, lung disease, and diabetes - to stay at home as much as possible.
Good hygiene practices like frequently washing and sanitizing hands, disinfecting common surfaces, and not touching your face are also important.
As the CDC’s chart below illustrates, by delaying the spread and “flattening the curve,” we can decrease the spike in demands on our hospitals and healthcare system, which will save lives.
Responsible actions now will have a large impact in the weeks and months ahead, and I applaud Governor DeWine and President Trump for taking decisive steps to help slow the spread of COVID-19. I was also proud to support the $2 trillion CARES Act and the $8.3 billion funding measure to help prevent, prepare, and respond to the spread. I am asking all Ohioans to take steps to “Flatten The Curve” to help our health care workers, our first responders, and the many Ohioans who are at higher risk. We are in this together, and together we will prevail.
COVID-19 Diagnostic Tests: For questions about development of COVID-19 diagnostic tests, here are several important resources:
- 24/7 Hotline for Diagnostics: If a developer, lab, manufacturer or health care provider has questions about testing or is experiencing spot shortages of testing, personal protective equipment, or other supplies, call FDA’s toll-free line at 1-888-463-6332 (1-888-INFO-FDA), then choose option (*). The line is available 24 hours a day to help address difficulties obtaining supplies for collecting patient samples for COVID-19 testing, including swabs, media needed for transport, and conservation of the samples – among other things. Please note, however, that FDA does not control the production volume or distribution of medical devices.
- Emergency Use Authorization (EUA) for COVID-19 Diagnostic Tests: If you need additional information for completing the EUA template, would like to know how to submit Pre-EUA/EUA submissions to FDA, or wish to consider an alternative specimen type, you may contact the Division of Microbiology Devices at (301) 348-1778 or email CDRH-EUA-Templates@fda.hhs.gov. Please note that FDA is unable to provide information on the status of any individual submissions (this is generally confidential commercial information) and FDA would encourage congressional offices to reach out to specific developers for the status of any pending product submissions.
Personal Protective Equipment: If you have questions or is experiencing spot shortages of personal protective equipment or other supplies, call FDA’s toll-free line at 1-888-463-6332 (1-888-INFO-FDA), then choose option (*). The line is available 24 hours a day to help address difficulties obtaining supplies. Please note, however, that FDA does not control the production volume or distribution of medical devices.
Vaccines and other biological product candidates: Biological product sponsors, including vaccine developers, wishing to develop vaccines can email firstname.lastname@example.org or call 1-800-835-4709 for further information.
Therapeutics and other drug product candidates: Sponsors wishing to develop therapeutics are encouraged to submit information and questions via the Pre-IND Consultation program. See https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/covid-19-therapeutics-general-information-interested-stakeholders or call 301-796-1500 for additional information on this program.
Clinical Trials: Sponsors who have questions regarding the conduct of clinical trials impacted by COVID-19 should contact clinicaltrialconduct-COVID19@fda.hhs.gov
Drug Shortages: If you are a healthcare provider and have questions or concerns about a drug shortage, related or unrelated to COVID-19, you should contact CDER’s Division of Drug Information (DDI) at 855-543-3784, 301-796-3400, or email@example.com. Also, FDA's Drug Shortage web page has information related to current shortages.
Food: If you are in the food industry and have a question for FDA, you can find information on common questions about food safety and COVID-19 here. If you need to contact FDA’s Center for Food Safety and Applied Nutrition about a COVID-19 related question, you may do so by submitting a question here.
Animal Drugs and Animal Food: If a constituent has questions or concerns related to COVID-19 and its impact on products regulated by FDA’s Center for Veterinary Medicine, they may contact AskCVM@fda.hhs.gov, and their inquiry will be routed to the appropriate subject matter expert for response. A list of known animal drug shortages is kept by FDA’s Center for Veterinary Medicine.
For more information, please visit FDA’s COVID-19 FAQ page.
OTHER TRUSTED RESOURCES
For the latest from the State of Ohio, visit www.coronavirus.ohio.gov. If you still have questions, you can call the Ohio Coronavirus Hotline at 1-833-4-ASK-ODH.
To learn the latest from the Centers for Disease Control and Prevention (CDC), visit https://www.cdc.gov/coronavirus.
CDC COVID-19 Homepage: www.cdc.gov/coronavirus/2019-ncov/index.html
CDC Steps to Prevent Illness: https://www.cdc.gov/coronavirus/2019-ncov/about/prevention.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fabout%2Fprevention-treatment.html
U.S. State Department: https://travel.state.gov/content/travel/en/traveladvisories/ea/covid-19-information.html
Ohio Department of Health: https://odh.ohio.gov/wps/portal/gov/odh/know-our-programs/Novel-Coronavirus/Resources-for-the-Public/
SBA Disaster Assistance: https://www.sba.gov/funding-programs/disaster-assistance
USDA Nutrition Programs Information: https://www.fns.usda.gov/disaster/pandemic/covid-19
Department of Labor FAQs: https://www.dol.gov/agencies/whd/pandemic/ffcra-questions
IRS Economic Impact Payments FAQs: https://www.irs.gov/newsroom/economic-impact-payments-what-you-need-to-know
To learn more about and report a coronavirus scam please visit the Treasury Departments information page: https://www.treasury.gov/tigta/contact.shtml#COVID